Both in pediatric and adult trials, as reported in the Tables 3 and 4 , we can find a positive trend in the results: a general reduction of infection rates, a reduction of their duration, a beneficial effect on symptoms, a reduction in the use of antibiotics.
← all excerpts
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.
1
—
—